Meet the Realbotix Robots: Less Robot, More Human
3:26
YouTubeCNET
Meet the Realbotix Robots: Less Robot, More Human
Meet the robots of Realbotix, a company which aims to make humanoid robots more human in both appearance and conversation. Read more on CNET: We Spoke to a $175K Robot at CES 2025 That's Almost Human https://cnet.us/nb5 0:00 Intro 0:18 Aria AI Robot Interview 1:45 Realbotix AI 2:04 Realbotix Interchangeable Faces 2:27 Realbotix Robots for sale ...
2M views10 months ago
Robotic Prostate Surgery
Improved robotic surgery at Cleveland Clinic shows significant progress in prostate cancer removal
2:50
Improved robotic surgery at Cleveland Clinic shows significant progress in prostate cancer removal
wkyc.com
Sep 7, 2022
Simple prostatectomy for BPH: Surgeons demonstrate robotic approaches | Urology Times
Simple prostatectomy for BPH: Surgeons demonstrate robotic approaches | Urology Times
urologytimes.com
2K viewsApr 24, 2018
Robot-assisted Radical Prostatectomy (RARP)
2:27
Robot-assisted Radical Prostatectomy (RARP)
YouTubeEuropean Association of
606.8K viewsNov 10, 2020
Top videos
Tesla's 'We, Robot' Event: Everything Revealed in 8 Minutes
7:32
Tesla's 'We, Robot' Event: Everything Revealed in 8 Minutes
YouTubeCNET
4.2M viewsOct 11, 2024
The Wild Robot | Final Trailer
2:22
The Wild Robot | Final Trailer
YouTubeUniversal Pictures
7.1M viewsSep 10, 2024
Elon Musk showcases ‘biggest product ever’ Tesla Optimus robot
1:07
Elon Musk showcases ‘biggest product ever’ Tesla Optimus robot
YouTubeThe Independent
869.6K views5 months ago
Prostatectomy Recovery Tips
NRG-GU006 trial for post-prostatectomy radiation therapy. Daniel Spratt, MD Case Comprehensive Cancer Center joins Jeff Michalski, MD, MBA, FACR, FASTRO Washington University in St. Louis to present the NRG GU006/BALANCE trial results, demonstrating PAM50 molecular subtypes as the first prospectively validated predictive biomarker guiding hormone therapy decisions in recurrent #ProstateCancer. #WatchNow on UroToday > bit.ly/4mONYa3 | UroToday
NRG-GU006 trial for post-prostatectomy radiation therapy. Daniel Spratt, MD Case Comprehensive Cancer Center joins Jeff Michalski, MD, MBA, FACR, FASTRO Washington University in St. Louis to present the NRG GU006/BALANCE trial results, demonstrating PAM50 molecular subtypes as the first prospectively validated predictive biomarker guiding hormone therapy decisions in recurrent #ProstateCancer. #WatchNow on UroToday > bit.ly/4mONYa3 | UroToday
FacebookUroToday
1 views11 hours ago
More on Localized Prostate Cancer
57:06
More on Localized Prostate Cancer
YouTubeUniversity of California
45 views23 hours ago
High Grade Prostate Cancer (Gleason 8 and 9) cure rates #roboticsurgery
0:55
High Grade Prostate Cancer (Gleason 8 and 9) cure rates #roboticsurgery
YouTubeProstate Cancer Treatment in
503 views2 weeks ago